go back

Nevada rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $977,237 · 10th–90th $0–$1,230,2690%20%10th90th$977,237Professionalmedian $489,779 · 10th–90th $489,779–$562,3410%50%90th$489,779$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $977,237.22 / $1,230,268.77
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $562,341.33
Anthem BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$0.03 / $0.03 / $0.03
Anthem BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $489,778.82
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $588,843.66
Hometown Health
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$512,861.38 / $512,861.38 / $512,861.38
Select Health
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $512,861.38
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$457,088.19 / $549,540.87 / $741,310.24